Clinical trial
Effect of Tiotropium (Spiriva) on Exercise Tolerance in COPD Patients
NCT00274508 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT00274508 |
|---|---|
| Title | Effect of Tiotropium (Spiriva) on Exercise Tolerance in COPD Patients |
| Official title | Effect of Tiotropium on Exercise Tolerance and Static and Dynamic Lung Volumes in COPD Patients (A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study) |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pulmonary Disease, Chronic Obstructive |
| Intervention type | Drug |
| Interventions | tiotropium bromide |
| Enrollment | 261 |
| Start date | Oct 10, 2000 |
| Primary completion | Jan 7, 2003 |
| First posted | Jan 11, 2006 |
| Last update posted | Dec 1, 2023 |
| Countries | Australia, Canada, Germany, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: